Cargando…

Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma

AIM: To elucidate the effect of expression of doublecortin and CaM kinase-like-1 (DCLK1) in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: Tumor specimens were obtained from 136 patients with pancreatic cancer who had undergone resection without preoperative therapy between January...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishio, Kohei, Kimura, Kenjiro, Amano, Ryosuke, Nakata, Bunzo, Yamazoe, Sadaaki, Ohira, Go, Miura, Kotaro, Kametani, Naoki, Tanaka, Hiroaki, Muguruma, Kazuya, Hirakawa, Kosei, Ohira, Masaichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569291/
https://www.ncbi.nlm.nih.gov/pubmed/28883702
http://dx.doi.org/10.3748/wjg.v23.i31.5764
_version_ 1783258964165656576
author Nishio, Kohei
Kimura, Kenjiro
Amano, Ryosuke
Nakata, Bunzo
Yamazoe, Sadaaki
Ohira, Go
Miura, Kotaro
Kametani, Naoki
Tanaka, Hiroaki
Muguruma, Kazuya
Hirakawa, Kosei
Ohira, Masaichi
author_facet Nishio, Kohei
Kimura, Kenjiro
Amano, Ryosuke
Nakata, Bunzo
Yamazoe, Sadaaki
Ohira, Go
Miura, Kotaro
Kametani, Naoki
Tanaka, Hiroaki
Muguruma, Kazuya
Hirakawa, Kosei
Ohira, Masaichi
author_sort Nishio, Kohei
collection PubMed
description AIM: To elucidate the effect of expression of doublecortin and CaM kinase-like-1 (DCLK1) in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: Tumor specimens were obtained from 136 patients with pancreatic cancer who had undergone resection without preoperative therapy between January 2000 and December 2013 at the Department of Surgical Oncology, Osaka City University. The resected specimens were analyzed for associations with clinicopathological data, including DCLK1 expression, epithelial mesenchymal transition (EMT) marker expression, and cancer stem cell (CSC) marker expression. Univariate and multivariate survival analyses were performed and we assessed the association between DCLK1 expression and clinicopathological factors, including the EMT marker and CSC marker. RESULTS: In total, 48.5% (66/136) of the pancreatic cancer samples were positive for DCLK1. Patients with DCLK1-positive tumors had significantly shorter survival times than those with DCLK1-negative tumors (median, 18.7 mo vs 49.5 mo, respectively; P < 0.0001). Positive DCLK1 expression correlated with histological grade (P = 0.0290), preoperative CA19-9 level (P = 0.0060), epithelial cell adhesion molecule (EpCAM) expression (P = 0.0235), and the triple-positive expression of CD44/CD24/EpCAM (P = 0.0139). On univariate survival analysis, five factors were significantly associated with worse overall survival: histological grade of G2 to G4 (P = 0.0091), high preoperative serum SPan-1 level (P = 0.0034), R1/2 (P < 0.0001), positive expression of DCLK1 (P < 0.0001) or CD44 (P = 0.0245). On multivariate survival analysis, R1/2 [odds ratio (OR) = 2.019, 95% confidence interval (CI): 1.380-2.933; P = 0.0004] and positive DCLK1 expression (OR = 1.848, 95%CI: 1.2854-2.661; P = 0.0009) were independent prognostic factors. CONCLUSION: DCLK1 expression was found to be an independent prognostic factor and it may play a crucial prognostic role by promoting acquisition of stemness.
format Online
Article
Text
id pubmed-5569291
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-55692912017-09-07 Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma Nishio, Kohei Kimura, Kenjiro Amano, Ryosuke Nakata, Bunzo Yamazoe, Sadaaki Ohira, Go Miura, Kotaro Kametani, Naoki Tanaka, Hiroaki Muguruma, Kazuya Hirakawa, Kosei Ohira, Masaichi World J Gastroenterol Retrospective Study AIM: To elucidate the effect of expression of doublecortin and CaM kinase-like-1 (DCLK1) in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: Tumor specimens were obtained from 136 patients with pancreatic cancer who had undergone resection without preoperative therapy between January 2000 and December 2013 at the Department of Surgical Oncology, Osaka City University. The resected specimens were analyzed for associations with clinicopathological data, including DCLK1 expression, epithelial mesenchymal transition (EMT) marker expression, and cancer stem cell (CSC) marker expression. Univariate and multivariate survival analyses were performed and we assessed the association between DCLK1 expression and clinicopathological factors, including the EMT marker and CSC marker. RESULTS: In total, 48.5% (66/136) of the pancreatic cancer samples were positive for DCLK1. Patients with DCLK1-positive tumors had significantly shorter survival times than those with DCLK1-negative tumors (median, 18.7 mo vs 49.5 mo, respectively; P < 0.0001). Positive DCLK1 expression correlated with histological grade (P = 0.0290), preoperative CA19-9 level (P = 0.0060), epithelial cell adhesion molecule (EpCAM) expression (P = 0.0235), and the triple-positive expression of CD44/CD24/EpCAM (P = 0.0139). On univariate survival analysis, five factors were significantly associated with worse overall survival: histological grade of G2 to G4 (P = 0.0091), high preoperative serum SPan-1 level (P = 0.0034), R1/2 (P < 0.0001), positive expression of DCLK1 (P < 0.0001) or CD44 (P = 0.0245). On multivariate survival analysis, R1/2 [odds ratio (OR) = 2.019, 95% confidence interval (CI): 1.380-2.933; P = 0.0004] and positive DCLK1 expression (OR = 1.848, 95%CI: 1.2854-2.661; P = 0.0009) were independent prognostic factors. CONCLUSION: DCLK1 expression was found to be an independent prognostic factor and it may play a crucial prognostic role by promoting acquisition of stemness. Baishideng Publishing Group Inc 2017-08-21 2017-08-21 /pmc/articles/PMC5569291/ /pubmed/28883702 http://dx.doi.org/10.3748/wjg.v23.i31.5764 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Nishio, Kohei
Kimura, Kenjiro
Amano, Ryosuke
Nakata, Bunzo
Yamazoe, Sadaaki
Ohira, Go
Miura, Kotaro
Kametani, Naoki
Tanaka, Hiroaki
Muguruma, Kazuya
Hirakawa, Kosei
Ohira, Masaichi
Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
title Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
title_full Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
title_fullStr Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
title_full_unstemmed Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
title_short Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
title_sort doublecortin and cam kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569291/
https://www.ncbi.nlm.nih.gov/pubmed/28883702
http://dx.doi.org/10.3748/wjg.v23.i31.5764
work_keys_str_mv AT nishiokohei doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT kimurakenjiro doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT amanoryosuke doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT nakatabunzo doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT yamazoesadaaki doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT ohirago doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT miurakotaro doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT kametaninaoki doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT tanakahiroaki doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT mugurumakazuya doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT hirakawakosei doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma
AT ohiramasaichi doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma